BEVERLY, Mass., July 02, 2021 (Globe NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF TSX-V: LXG) (the “Corporation”), a molecular diagnostics...
BEVERLY, Mass., July 02, 2021 (Globe NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF TSX-V: LXG) (the “Corporation”), a molecular diagnostics...